RAC 1.78% $1.43 race oncology ltd

Ann: Bisantrene Phase 2 AML data presented at ASH conference

  1. lightbulb Created with Sketch. 851
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.